"HLA-DQ beta-Chains" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transmembrane proteins that form the beta subunits of the HLA-DQ antigens.
| Descriptor ID |
D059866
|
| MeSH Number(s) |
D12.776.395.550.509.400.430.750 D12.776.543.550.440.400.430.750 D23.050.301.500.400.400.430.750 D23.050.301.500.450.400.430.750 D23.050.705.552.410.400.430.750 D23.050.705.552.450.400.430.750
|
| Concept/Terms |
HLA-DQ beta-Chains- HLA-DQ beta-Chains
- HLA DQ beta Chains
- beta-Chains, HLA-DQ
- HLA Class II Histocompatibility Antigen, DQ beta Chains
|
Below are MeSH descriptors whose meaning is more general than "HLA-DQ beta-Chains".
Below are MeSH descriptors whose meaning is more specific than "HLA-DQ beta-Chains".
This graph shows the total number of publications written about "HLA-DQ beta-Chains" by people in this website by year, and whether "HLA-DQ beta-Chains" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2017 | 2 | 3 | 5 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HLA-DQ beta-Chains" by people in Profiles.
-
The influence of HLA genotype on the severity of COVID-19 infection. HLA. 2021 07; 98(1):14-22.
-
Association between the HLA genotype and the severity of COVID-19 infection among South Asians. J Med Virol. 2021 07; 93(7):4430-4437.
-
NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome. Med Hypotheses. 2020 Dec; 145:110342.
-
A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients. Int J Immunogenet. 2020 Aug; 47(4):324-328.
-
Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity. J Neurol. 2019 Apr; 266(4):982-989.
-
Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome. Sci Rep. 2018 05 08; 8(1):7224.
-
HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ ß chains. Pediatr Res. 2018 03; 83(3):564-572.
-
The association of HLA-DQB1*0602 but not HLA-DRB1*15 with obstructive sleep apnea. Clin Invest Med. 2017 08 29; 40(4):E167-E175.
-
Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Sci Transl Med. 2017 05 10; 9(389).
-
Absence of autoreactive CD4+ T-cells targeting HLA-DQA1*01:02/DQB1*06:02 restricted hypocretin/orexin epitopes in narcolepsy type 1 when detected by EliSpot. J Neuroimmunol. 2017 08 15; 309:7-11.